{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:20:17Z","timestamp":1777537217223,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29197-7","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:48:41Z","timestamp":1767026921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational screening and molecular modeling of probiotic-derived peptides targeting the conserved HR1 domain of SARS-CoV-2 spike protein"],"prefix":"10.1038","volume":"15","author":[{"given":"Alireza","family":"Sattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar Saadaie","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Sadat Jalilzadeh","family":"Ghahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golsa Nayeb Ghanbar","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najaf Allahyari","family":"Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"4","key":"29197_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1099\/0022-1317-64-4-761","volume":"64","author":"S Siddell","year":"1983","unstructured":"Siddell, S., Wege, H. & Ter Meulen, V. The biology of coronaviruses. J. Gen. Virol. 64 (4), 761\u2013776 (1983).","journal-title":"J. Gen. Virol."},{"issue":"21","key":"29197_CR2","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1128\/JVI.05512-11","volume":"85","author":"SK Lau","year":"2011","unstructured":"Lau, S. K. et al. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J. Virol. 85 (21), 11325\u201311337 (2011).","journal-title":"J. Virol."},{"issue":"7807","key":"29197_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 Spike receptor-binding domain bound to the ACE2 receptor. Nature 581 (7807), 215\u2013220 (2020).","journal-title":"Nature"},{"key":"29197_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-pharmtox-061220-093932","volume":"61","author":"H Sivaraman","year":"2021","unstructured":"Sivaraman, H. et al. Structural basis of SARS-CoV-2\u2013and SARS-CoV\u2013receptor binding and small-molecule blockers as potential therapeutics. Annu. Rev. Pharmacol. Toxicol. 61, 465\u2013493 (2021).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"29197_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y. et al. Structural and functional properties of SARS-CoV-2 Spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41 (9), 1141\u20131149 (2020).","journal-title":"Acta Pharmacol. Sin."},{"issue":"5742","key":"29197_CR6","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li, F. et al. Structure of SARS coronavirus Spike receptor-binding domain complexed with receptor. Science 309 (5742), 1864\u20131868 (2005).","journal-title":"Science"},{"issue":"16","key":"29197_CR7","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","volume":"77","author":"BJ Bosch","year":"2003","unstructured":"Bosch, B. J. et al. The coronavirus Spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77 (16), 8801\u20138811 (2003).","journal-title":"J. Virol."},{"key":"29197_CR8","doi-asserted-by":"publisher","first-page":"117863022312178","DOI":"10.1177\/11786302231217805","volume":"17","author":"A Girma","year":"2023","unstructured":"Girma, A. The many mutations of the COVID-19 variant: current perspectives on EG. 5\/Eris. Environ. Health Insights. 17, 11786302231217805 (2023).","journal-title":"Environ. Health Insights"},{"issue":"1","key":"29197_CR9","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1038\/s41467-023-43703-3","volume":"14","author":"K Khan","year":"2023","unstructured":"Khan, K. et al. Evolution and neutralization escape of the SARS-CoV-2 BA. 2.86 subvariant. Nat. Commun. 14 (1), 8078 (2023).","journal-title":"Nat. Commun."},{"key":"29197_CR10","unstructured":"Organization, W. H. Statement on the antigen composition of COVID-19 vaccines  (2023)."},{"key":"29197_CR11","doi-asserted-by":"publisher","first-page":"170328","DOI":"10.1016\/j.peptides.2020.170328","volume":"130","author":"R Ling","year":"2020","unstructured":"Ling, R. et al. In Silico design of antiviral peptides targeting the Spike protein of SARS-CoV-2. Peptides 130, 170328 (2020).","journal-title":"Peptides"},{"issue":"4","key":"29197_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1472-765X.1994.tb00943.x","volume":"19","author":"M Torreblanca","year":"1994","unstructured":"Torreblanca, M., Meseguer, I. & Ventosa, A. Production of Halocin is a practically universal feature of archaeal halophilic rods. Lett. Appl. Microbiol. 19 (4), 201\u2013205 (1994).","journal-title":"Lett. Appl. Microbiol."},{"issue":"3","key":"29197_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0300-9084(88)90206-4","volume":"70","author":"TR Klaenhammer","year":"1988","unstructured":"Klaenhammer, T. R. Bacteriocins of lactic acid bacteria. Biochimie 70 (3), 337\u2013349 (1988).","journal-title":"Biochimie"},{"key":"29197_CR14","doi-asserted-by":"publisher","first-page":"pbay038","DOI":"10.1093\/database\/bay038","volume":"2018","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. StraPep: a structure database of bioactive peptides. Database 2018, pbay038 (2018).","journal-title":"Database"},{"issue":"1","key":"29197_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-10-22","volume":"10","author":"R Hammami","year":"2010","unstructured":"Hammami, R. et al. BACTIBASE second release: a database and tool platform for bacteriocin characterization. BMC Microbiol. 10 (1), 1\u20135 (2010).","journal-title":"BMC Microbiol."},{"issue":"W1","key":"29197_CR16","doi-asserted-by":"publisher","first-page":"W278","DOI":"10.1093\/nar\/gky383","volume":"46","author":"AJ van Heel","year":"2018","unstructured":"van Heel, A. J. et al. BAGEL4: a user-friendly web server to thoroughly mine RiPPs and bacteriocins. Nucleic Acids Res. 46 (W1), W278\u2013W281 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"29197_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28 (1), 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"29197_CR18","doi-asserted-by":"publisher","first-page":"W276","DOI":"10.1093\/nar\/gkac240","volume":"50","author":"F Madeira","year":"2022","unstructured":"Madeira, F. et al. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 50 (W1), W276\u2013W279 (2022).","journal-title":"Nucleic Acids Res."},{"key":"29197_CR19","doi-asserted-by":"crossref","unstructured":"Mitra, D., Pal, A. K.& Das, P. K.  Mohapatra Intra-protein interactions of SARS-CoV-2 and SARS: a bioinformatic analysis for plausible explanation regarding stability, divergency, and severity. Syst. Microbiol. Biomanufact. 2 (4), 653\u2013664 (2022).","DOI":"10.1007\/s43393-022-00091-x"},{"issue":"20","key":"29197_CR20","doi-asserted-by":"publisher","first-page":"10239","DOI":"10.1080\/07391102.2021.1942210","volume":"40","author":"D Mitra","year":"2022","unstructured":"Mitra, D. et al. Study of potentiality of dexamethasone and its derivatives against Covid-19. J. Biomol. Struct. Dyn.  40 (20), 10239\u201310249 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"29197_CR21","doi-asserted-by":"crossref","unstructured":"Biswas, I. & Mitra, D. Comparative analysis of RuBisCO evolution and intrinsic differences: insights from in silico assessment in cyanobacteria, monocot, and dicot plants. Biol. Life Sci. Forum  27 (1),  44 (2023).","DOI":"10.3390\/IECAG2023-15820"},{"issue":"4","key":"29197_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","volume":"30","author":"S Xia","year":"2020","unstructured":"Xia, S. et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its Spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 30 (4), 343\u2013355 (2020).","journal-title":"Cell Res."},{"key":"29197_CR23","unstructured":"Biovia, D. S. Discovery studio modeling environment, Release  (2017)."},{"issue":"1","key":"29197_CR24","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1038\/s41467-022-32262-8","volume":"13","author":"D Mannar","year":"2022","unstructured":"Mannar, D. et al. SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization. Nat. Commun. 13 (1), 4696 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"29197_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41467-022-28324-6","volume":"13","author":"JW Saville","year":"2022","unstructured":"Saville, J. W. et al. Structural and biochemical rationale for enhanced Spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat. Commun. 13 (1), 742 (2022).","journal-title":"Nat. Commun."},{"issue":"6582","key":"29197_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.abn7760","volume":"375","author":"D Mannar","year":"2022","unstructured":"Mannar, D. et al. SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of Spike protein\u2013ACE2 complex. Science 375 (6582), 760\u2013764 (2022).","journal-title":"Science"},{"issue":"W1","key":"29197_CR27","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46 (W1), W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"29197_CR28","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41587-021-01040-0","volume":"39","author":"K Kalia","year":"2021","unstructured":"Kalia, K., Saberwal, G. & Sharma, G. The lag in SARS-CoV-2 genome submissions to GISAID. Nat. Biotechnol. 39 (9), 1058\u20131060 (2021).","journal-title":"Nat. Biotechnol."},{"key":"29197_CR29","doi-asserted-by":"crossref","unstructured":"Hollingsworth, S. A. & Karplus, P. A. A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins  (2010).","DOI":"10.1515\/bmc.2010.022"},{"issue":"6","key":"29197_CR30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","volume":"36","author":"G Studer","year":"2019","unstructured":"Studer, G. et al. QMEANDisCo\u2014distance constraints applied on model quality Estimation. Bioinformatics 36 (6), 1765\u20131771 (2019).","journal-title":"Bioinformatics"},{"key":"29197_CR31","doi-asserted-by":"publisher","first-page":"729513","DOI":"10.3389\/fmolb.2021.729513","volume":"8","author":"RV Honorato","year":"2021","unstructured":"Honorato, R. V. et al. Structural biology in the clouds: the WeNMR-EOSC ecosystem. Front. Mol. Biosci. 8, 729513 (2021).","journal-title":"Front. Mol. Biosci."},{"issue":"7","key":"29197_CR32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","volume":"125","author":"C Dominguez","year":"2003","unstructured":"Dominguez, C., Boelens, R. & Bonvin, A. M. HADDOCK: a protein\u2009\u2013\u2009protein Docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 (7), 1731\u20131737 (2003).","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"29197_CR33","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In Silico approach for predicting toxicity of peptides and proteins. PloS One. 8 (9), e73957 (2013).","journal-title":"PloS One"},{"issue":"suppl_2","key":"29197_CR34","doi-asserted-by":"publisher","first-page":"W202","DOI":"10.1093\/nar\/gkl343","volume":"34","author":"S Saha","year":"2006","unstructured":"Saha, S. & Raghava, G. P. S. AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res. 34 (suppl_2), W202\u2013W209 (2006).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"29197_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4155\/fmc-2016-0188","volume":"9","author":"TS Win","year":"2017","unstructured":"Win, T. S. et al. HemoPred: a web server for predicting the hemolytic activity of peptides. Future Med. Chem. 9 (3), 275\u2013291 (2017).","journal-title":"Future Med. Chem."},{"issue":"12","key":"29197_CR36","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.3390\/ijms20122950","volume":"20","author":"V Laengsri","year":"2019","unstructured":"Laengsri, V. et al. TargetAntiAngio: a sequence-based tool for the prediction and analysis of anti-angiogenic peptides. Int. J. Mol. Sci. 20 (12), 2950 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"29197_CR37","first-page":"263952","volume":"2013","author":"SK Dhanda","year":"2013","unstructured":"Dhanda, S. K. et al. Prediction of IL4 inducing peptides. J. Immunol. Res. 2013 (1), 263952 (2013).","journal-title":"J. Immunol. Res."},{"issue":"16","key":"29197_CR38","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26 (16), 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"issue":"5","key":"29197_CR39","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1080\/07391102.2023.2300408","volume":"43","author":"D Mitra","year":"2025","unstructured":"Mitra, D. et al. Inhibition of respiratory syncytial virus by Daclatasvir and its derivatives: synthesis of computational derivatives as a new drug development. J. Biomol. Struct. Dyn. 43 (5), 2440\u20132462 (2025).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"29197_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21 (6), 361\u2013379 (2023).","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"29197_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/v14030640","volume":"14","author":"N Magazine","year":"2022","unstructured":"Magazine, N. et al. Mutations and evolution of the SARS-CoV-2 Spike protein. Viruses 14 (3), 640 (2022).","journal-title":"Viruses"},{"issue":"1","key":"29197_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41392-021-00733-x","volume":"6","author":"YW Zhou","year":"2021","unstructured":"Zhou, Y. W. et al. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal. Transduct. Target. Therapy. 6 (1), 317 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"3","key":"29197_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du, L. et al. The Spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7 (3), 226\u2013236 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"29197_CR44","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.imu.2021.100515","volume":"23","author":"N Balmeh","year":"2021","unstructured":"Balmeh, N., Mahmoudi, S. & Fard, N. A. Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease. Inf. Med. Unlocked. 23, 100515 (2021).","journal-title":"Inf. Med. Unlocked"},{"issue":"4","key":"29197_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"MT ul Qamar","year":"2020","unstructured":"ul Qamar, M. T. et al. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 10 (4), 313\u2013319 (2020).","journal-title":"J. Pharm. Anal."},{"key":"29197_CR46","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3389\/fmicb.2020.01796","volume":"11","author":"R Alexpandi","year":"2020","unstructured":"Alexpandi, R. et al. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and Spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in Silico analysis. Front. Microbiol. 11, 1796 (2020).","journal-title":"Front. Microbiol."},{"key":"29197_CR47","doi-asserted-by":"publisher","first-page":"173759","DOI":"10.1016\/j.ejphar.2020.173759","volume":"891","author":"C Mouffouk","year":"2021","unstructured":"Mouffouk, C. et al. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), Spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). Eur. J. Pharmacol. 891, 173759 (2021).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"29197_CR48","doi-asserted-by":"publisher","first-page":"106012","DOI":"10.1016\/j.ijantimicag.2020.106012","volume":"56","author":"R Yu","year":"2020","unstructured":"Yu, R. et al. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular Docking. Int. J. Antimicrob. Agents. 56 (2), 106012 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"29197_CR49","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants.  Emerg. Microbes Infect.   10,  1519\u20131529 (2021).","DOI":"10.1080\/22221751.2021.1957720"},{"issue":"5","key":"29197_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s15010-021-01677-8","volume":"49","author":"AM Almehdi","year":"2021","unstructured":"Almehdi, A. M. et al. SARS-CoV-2 Spike protein: pathogenesis, vaccines, and potential therapies. Infection 49 (5), 855\u2013876 (2021).","journal-title":"Infection"},{"issue":"11","key":"29197_CR51","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1080\/07391102.2020.1775123","volume":"39","author":"F Anwar","year":"2021","unstructured":"Anwar, F. et al. Antiviral effects of probiotic metabolites on COVID-19. J. Biomol. Struct. Dyn. 39 (11), 4175\u20134184 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"29197_CR52","doi-asserted-by":"crossref","unstructured":"Kurpe, S. R. et al. Antimicrobial and amyloidogenic activity of peptides. Can antimicrobial peptides be used against SARS-CoV-2? Int. J. Mol. Sci.  21 (24), 9552 (2020).","DOI":"10.3390\/ijms21249552"},{"key":"29197_CR53","doi-asserted-by":"crossref","unstructured":"Abedi Dorcheh, F. et al. Investigation of the mutated antimicrobial peptides to inhibit ACE2, TMPRSS2 and GRP78 receptors of SARS-CoV-2 and angiotensin II type 1 receptor (AT1R) as well as controlling COVID-19 disease. J. Biomol. Struct. Dyn. 2023,  1\u201324  (2023).","DOI":"10.1080\/07391102.2023.2292307"},{"issue":"3","key":"29197_CR54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/135965350501000301","volume":"10","author":"BJ Zheng","year":"2005","unstructured":"Zheng, B. J. et al. Synthetic peptides outside the Spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir. Ther. 10 (3), 393\u2013403 (2005).","journal-title":"Antivir. Ther."},{"issue":"23","key":"29197_CR55","doi-asserted-by":"publisher","first-page":"17486","DOI":"10.1021\/acs.jmedchem.1c01681","volume":"64","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. Stapled peptides targeting SARS-CoV-2 Spike protein HR1 inhibit the fusion of virus to its cell receptor. J. Med. Chem. 64 (23), 17486\u201317495 (2021).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29197-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:05:07Z","timestamp":1777395907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29197-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["29197"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29197-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44952"}}